Click Here to Register »

Executive Sponsors

Caprion
Covance
VirtualScopics, Inc.

Associate Sponsors

Cancer Genetics
HTG Molecular
IntelliCyt
Neon Therapeutics
Ventana

Supporting Sponsors

Defined health

Exhibitors

Abcam
BioMedical Systems
Biotech Corporation
Loncar Investments
Personalis
Provecs Medical
World Courier

Supporting Partners

Cancer Research Institute
CIMT
SITC

Media Partners

Advances in Modern Oncology Research, AMOR
BioCompare
BioPharm Clinical
BioPharma Dive
Clinical Leader
GEN
K BioSciences
Medical News Today
Pharma VOICE
Technology Networks

IO 360 Supports

Dance Against Cancer
Emily Whitehead Foundation

Overview

Welcome to the 3rd annual Immuno-Oncology 360° event taking place February 2-3, 2017 in NYC. Designed by lead Advisors Dr Axel Hoos (GSK) and Dr James Gulley (NCI) the program provides a unique 360-degree approach addressing the most-up-to-date information regarding business aspects, clinical advancements and scientific data will help accelerate clinical trials and FDA approval, ultimately transform the way cancer is treated.

2017 Featured Speakers

AxelHoos_color

Co-Chair Axel Hoos, MD, PhD GSK

James Gulley Color

Co-Chair James Gulley, MD, PhD NCI

Keynote James Allison, PhD MD Anderson

 

IO360° Videos


With rapid development of cancer immunotherapy drug development, breakthrough FDA approval status, and fast-tracking clinical trials, competition is fierce. The science behind immune-based therapies is driving rapid change. Both small and large companies are racing to bring game-changing therapies to the market and in many cases, partnering to maximize on combination therapies. As a result, innovative approaches and developments are also creating increased momentum for investment/business development opportunities.

Hoos_Gulley

2016 IO360 Co-chairs Dr. Axel Hoos, GSK and Dr. James Gulley, NCI

Jedd_Kate

Dr. Jedd Wolchok, MSCKK and Kate Woda, The Conference Forum

June

Dr. Carl June, University of Pennsylvania delivers Keynote at IO360 2016

 

 

 

 

 

 

 

 

 

 

 

June_tcf_advisors

Left to Right: Dr. Carl June, UPenn, Kate Woda and Valerie Bowling, The Conference Forum, Dr. James Gulley, NCI and Dr. Axel Hoos, GSK

 

We are still in the process of producing the event and look forward to announcing the agenda and speaking faculty soon. Let us know if you have questions, suggestions or an interest in being part of the event. Contact us at service@tcfllc.org.

We look forward to seeing you in February!

Sincerely,

Kate Woda B&W

 

Kate Woda
Conference Director

 

Valerie Bowling New

 

Valerie Bowling
Executive Director

 

Jessica Rothenberg B&W

 

Jessica Rothenberg
Marketing Director

 

Meredith Sands B&W

 

Meredith Sands
Executive Director, Business Development

 

Elizabeth Bard B&W

 

Elizabeth Bard
Business Development Manager

 

Geeta-BW

 

Geeta Bachani
Business Development Manager

 

Bridget Murphy B&W

 

Bridget Murphy
Conference Logistics Planner